L (2000-2009)

*older Articles in Pre-2000 List

LEGIONNAIRES DISEASE
LEISHMANIASIS
LIVER DISEASE-NON HEPATITIS* (See Also HEPATITIS)
LONG TERM USE EFFECTS*
LUNG FUNCTION*
LUPUS ERYTHEMATOSUS
LYME DISEASE


LEGIONNAIRES DISEASE
Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN -gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection (full–2000) http://www.jimmunol.org/content/164/12/6461.long
The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2 (full–2004) http://www.jleukbio.org/content/76/4/854.long
CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/18792785
top


LEISHMANIASIS
Biologically Active Cannabinoids from High-Potency Cannabis sativa (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19344127/abstract/Biologically_Active_Cannabinoids_from_High_Potency_Cannabis_sativa


LIVER DISEASE-NON HEPATITIS
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12190187
A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation (full–2003) http://molpharm.aspetjournals.org/content/64/6/1334.full
The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/13679241
Pathogenesis and treatment of pruritus in patients with cholestasis (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12664347
Treatment of the Pruritus of Cholestasis (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15527716
The endocannabinoid system in chronic liver disease (full–2005) http://www.medigraphic.com/pdfs/hepato/ah-2005/ah054c.pdf
(Marijuana/Hash) Endocannabinoids and liver disease – review (full–2005) http://www.natap.org/2005/HCV/091905_01.htm
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087161/?tool=pmcentrez
Roles of anandamide in the hepatic microcirculation in cirrhotic rats (full–2005) http://ajpgi.physiology.org/content/290/2/G328.full?sid=c16d770d-cd17-48c9-bbde-26f38f5eeb67
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16054069
Antifibrogenic role of the cannabinoid receptor CB2 in the liver (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15765409
Effect of Cannabis sativa L. Seed (Hempseed) on Serum Lipid and Protein Profiles of Rat (full–2006) http://scialert.net/qredirect.php?doi=pjn.2006.585.588&linkid=pdf
Endocannabinoid Degradation and Oxidative Defense Mechanisms Determine Anandamide-induced Cell Death in Liver Cell Populations (abst–2006) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2006-931661
CB2 receptors as new therapeutic targets for liver diseases (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219531/?tool=pubmed
Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full-2007) http://www.jleukbio.org/cgi/content/full/82/6/1382
Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase (full-2007) http://www.fasebj.org/content/21/10/2431.full
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225474/?tool=pmcentrez
top
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225476/?tool=pmcentrez
Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation (full–2007) http://ajpgi.physiology.org/content/294/2/G506.full
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms (full–2007) http://journals.tums.ac.ir/upload_files/pdf/_/6670.pdf
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17952109
CB2 receptors as new therapeutic targets for liver diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219531/?tool=pubmed
Role of cannabinoids in chronic liver diseases (full–2008) http://www.wjgnet.com/1007-9327/full/v14/i40/6109.htm
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver (full–2008) http://ajpgi.physiology.org/content/294/1/G9.full?sid=872637e5-97b2-4103-aaf0-b3e8f6f0eb64
Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis (full–2008) http://ajpgi.physiology.org/content/294/2/G357.full?sid=872637e5-97b2-4103-aaf0-b3e8f6f0eb64
Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376822/?tool=pmcentrez
Endocannabinoids and Liver Disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis (full-2008) http://ajpgi.physiology.org/cgi/content/full/294/5/G1101
Endocannabinoids and Liver Disease. V. Endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis (full–2008) http://ajpgi.physiology.org/content/295/4/G649.full?sid=c16d770d-cd17-48c9-bbde-26f38f5eeb67
Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats (full–2008) http://jpet.aspetjournals.org/content/324/2/475.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block
Endocannabinoids and the Control of Energy Homeostasis (full–2008) http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects (abst–2008) http://gut.bmj.com/content/57/8/1140.abstract
Cox–2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells through generation of prostaglandingycerol esters (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2008-1037457
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/19195630
Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/19086956
top
Endocannabinoids in liver disease and hepatic encephalopathy (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18781986
The endocannabinoid system as a novel target for the treatment of liver fibrosis (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/17412522
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects (abst-2008) http://gut.bmj.com/content/57/8/1140.abstract
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688760/?tool=pubmed
Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology (full–2009) http://www.biomedcentral.com/1471-230X/9/75
Cannabinoids as novel anti-inflammatory drugs (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed
Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology (full-2009) http://www.biomedcentral.com/1471-230X/9/75
Cannabinoids as novel anti-inflammatory drugs (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed
Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c (full–2009) https://www.jstage.jst.go.jp/article/jphs/109/4/109_08182FP/_pdf
Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19441010/abstract/
The role of CB2 cannabinoid receptor and Leptin in hepatic fibrosis via lymphocyte alterations and HSC phagocytosis (abst–2009) http://www.docstoc.com/docs/76792678/The-role-of-CB2-cannabinoid-receptor-and-Leptin-in-hepatic-
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19596476/abstract/Cannabidiol_ameliorates_cognitive_and_motor_impairments_in_mice_with_bile_duct_ligation_
Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19399401
Science: Oral intake of a cannabinoid together with a meal improved bioavailability by avoiding first-pass metabolism (news-2009) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=291#2


LONG TERM USE EFFECTS
Neuropsychological Performance in Long-term Cannabis Users (full–2001) http://archpsyc.amaassn.org/cgi/content/full/58/10/909?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2880&resourcetype=HWCIT
The pharmacologic effects of daily marijuana smoking in humans (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/1666929
Cognitive Measures in Long-term Cannabis Users (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12412835
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids (abst–2003) http://dl.begellhouse.com/journals/7b004699754c9fe6,5aa33979065f2aa3,42019b6a7dd932fb.html
Heavy Marijuana Use Doesn’t Damage Brain (news–2003) http://www.webmd.com/mental-health/news/20030701/heavy-marijuana-use-doesnt-damage-brain
top
Minimal Long-Term Effects Of Marijuana Use Found In Central Nervous System By UCSD Researchers (news–2003) http://www.sciencedaily.com/releases/2003/06/030630112652.htm
Survey of Australians using cannabis for medical purposes (full–2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1262744&tool=pmcentrez
Lack of hippocampal volume change in long-term heavy cannabis users (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15804878
Long-term effects of exposure to cannabis (abst–2005) http://www.sciencedirect.com/science/article/pii/S1471489204001973
Using Marijuana in Adulthood: the Experience of a Sample of Users in Oklahoma City (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16537332
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17086911
Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175501/?tool=pubmed
Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/20590564
The morphology of the immune system in opiomania, cannabism, and polynarcotism (abst–2009) http://www.unboundmedicine.com/medline/ebm/record/19938701/full_citation/%5BThe_morphology_of_the_immune_system_in_opiomania_cannabism_and_polynarcotism%5D
Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19399401


LUNG FUNCTION
Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation (full–2000) http://tinyurl.com/h8samug
Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574152/
The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2 (full–2004) http://www.jleukbio.org/content/76/4/854.long
Cannabinoid Receptor Agonists Inhibit Sensory Nerve Activation in Guinea Pig Airways (abst–2004) http://www.atsjournals.org/doi/full/10.1164/rccm.200306-775OC#.VqMR01JA44A
Cannabinoids and the immune system. Of men, mice and cells (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15221424
Long-term effects of exposure to cannabis (abst–2005) http://www.sciencedirect.com/science/article/pii/S1471489204001973
Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360494/?tool=pmcentrez
Effects of Marijuana Smoking on Pulmonary Function and Respiratory Complications: A Systematic Review (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720277/?tool=pmcentrez
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042924/?tool=pubmed
top
“Usual” cannabis abuse producing an unusual incident (abst–2007) (The Valsalva maneuver is performed by attempting to forcibly exhale while keeping the mouth and nose closed. Don’t do it!) http://www.ncbi.nlm.nih.gov/pubmed/17342632
Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17643417
No Decrease in Pulmonary Function Associated with Long-Term Cannabis Smoking, Study Says (news-2007) http://www.illinoisnorml.org/content/view/366/27/


LUPUS ERYTHEMATOSUS
Systemic Lupus Erythematosus by Lisa Swiderski (anecdotal-undated) http://rxmarijuana.com/lupus.htm
Lupus by Randi Cox (anecdotal–undated) http://rxmarijuana.com/shared_comments/lupus2.htm
Cannabis May Suppress Immune System (news-2003) http://lupus.webmd.com/news/20030415/cannabis-may-suppress-immune-system
Systemic Lupus by Dawn (anecdotal-2005) http://www.erowid.org/experiences/exp.php?ID=49481
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18040689


LYME DISEASE
Lyme Disease by Cynkay Morningstar (anecdotal–undated) http://rxmarijuana.com/shared_comments/Lyme_Disease.htm
Lyme Disease – Cannabis Treatment (news/anecdotal–undated) http://medicalmarijuana.com/medical-uses/condition.cfm?conID=55


Advertisements